Curcumin protects against NMDA-induced toxicity: A possible role for NR2A subunit

Investigative Ophthalmology and Visual Science

Volumn 52, Issue 2, 2011, Pages 1070-1077

  Matteucci, Andrea ^a   Cammarota, Roberta ^b   Paradisi, Silvia ^a   Varano, Monica ^c   Balduzzi, Maria ^d   Leo, Lanfranco ^a   Bellenchi, Gian C ^a   de Nuccio, Chiara ^a   Carnovale Scalzo, Giovanna ^e   Scorcia, Giovanni ^e   Frank, Claudio ^a   Mallozzi, Cinzia ^a   di Stasi, Annamaria M ^a   Visentin, Sergio ^a   Malchiodi Albedi, Fiorella ^a  

^a ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^b UNIVERSITY OF ROME TOR VERGATA   (Italy)

^c IRCCS FONDAZIONE BIETTI   (Italy)

^d ENEA C R CASACCIA   (Italy)

^e UNIVERSITY MAGNA GRAECIA OF CATANZARO   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM ION; CURCUMIN; FURA 2 ACETOXYMETHYL ESTER; N METHYL DEXTRO ASPARTIC ACID; N METHYL DEXTRO ASPARTIC ACID RECEPTOR 2A; ALPHA AMINO 3 HYDROXY 5 METHYL 4 ISOXAZOLEPROPIONIC ACID; AMINO ACID RECEPTOR BLOCKING AGENT; AMINO ACID RECEPTOR STIMULATING AGENT; CALCIUM; DIZOCILPINE MALEATE; KAINIC ACID; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; N METHYLASPARTIC ACID; NEUROPROTECTIVE AGENT; NR2A NMDA RECEPTOR;

ANIMAL CELL; ARTICLE; BRAIN NERVE CELL; CALCIUM CELL LEVEL; CALCIUM CURRENT; CELL LEVEL; CELL MEMBRANE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG MECHANISM; EMBRYO; EXCITOTOXICITY; FLUOROMETRY; HIPPOCAMPUS; IMMUNOCYTOCHEMISTRY; INTRACELLULAR RECORDING; NERVE CELL NECROSIS; NERVOUS SYSTEM ELECTROPHYSIOLOGY; NEUROMODULATION; NEUROPROTECTION; NICK END LABELING; NONHUMAN; PATCH CLAMP; PRIORITY JOURNAL; PROTEIN DEPHOSPHORYLATION; PROTEIN FUNCTION; PROTEIN MODIFICATION; PROTEIN SYNTHESIS; RAT; RECEPTOR DENSITY; RETINA NERVE CELL; WESTERN BLOTTING; ANIMAL; APOPTOSIS; CELL CULTURE; DOSE RESPONSE; DRUG EFFECT; FEMALE; IMMUNOHISTOCHEMISTRY; METABOLISM; PATHOLOGY; PREGNANCY; PRENATAL DEVELOPMENT; RETINA; TIME; WISTAR RAT;

ALPHA-AMINO-3-HYDROXY-5-METHYL-4-ISOXAZOLEPROPIONIC ACID; ANIMALS; APOPTOSIS; BLOTTING, WESTERN; CALCIUM; CELLS, CULTURED; CURCUMIN; DIZOCILPINE MALEATE; DOSE-RESPONSE RELATIONSHIP, DRUG; EXCITATORY AMINO ACID AGONISTS; EXCITATORY AMINO ACID ANTAGONISTS; FEMALE; HIPPOCAMPUS; IMMUNOHISTOCHEMISTRY; IN SITU NICK-END LABELING; KAINIC ACID; N-METHYLASPARTATE; NEUROPROTECTIVE AGENTS; PATCH-CLAMP TECHNIQUES; PREGNANCY; RATS; RATS, WISTAR; RECEPTORS, N-METHYL-D-ASPARTATE; RETINA; TIME FACTORS;

EID: 79953283388     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.10-5966     Document Type: Article

References (31)

1. Chainani-Wu N. Safety and anti-inflammatory activity of curcumin: a component of turmeric (Curcuma longa). J Altern Complement Med. 2003;9:161-168.
2. Kuhad A, Chopra K. Curcumin attenuates diabetic encephalopathy in rats: behavioral and biochemical evidences. Eur J Pharmacol. 2007;576:34-42.
3. Aggarwal BB, Harikumar KB. Potential therapeutic effects of curcumin, the anti inflammatory agent, against neurodegenerative, cardiovascular, pulmonary, metabolic, autoimmune and neoplastic diseases. Int J Biochem Cell Biol. 2009;41:40-59.
4. Park C, Moon DO, Choi IW, et al. Curcumin induces apoptosis and inhibits prostaglandin E(2) production in synovial fibroblasts of patients with rheumatoid arthritis. Int J Mol Med. 2007;20:365-372.
5. Aggarwal BB, Kumar A, Bharti AC. Anticancer potential of curcumin: preclinical and clinical studies. Anticancer Res. 2003; 23:363-983.
6. Xie L, Li XK, Funeshima-Fuji N, et al. Amelioration of experimental autoimmune encephalomyelitis by curcumin treatment through inhibition of IL-17 production. Int Immunopharmacol. 2009;9: 575-581.
7. Frautschy SA, Hu W, Kim P, et al. Phenolic anti-inflammatory antioxidant reversal of Abeta-induced cognitive deficits and neuropathology. Neurobiol Aging. 2001;22:993-1005.
8. Yang F, Lim GP, Begum AN, et al. Curcumin inhibits formation of amyloid beta oligomers and fibrils, binds plaques, and reduces amyloid in vivo. J Biol Chem. 2005;280:5892-5901.
9. Garcia-Alloza M, Borrelli LA, Rozkalne A, Hyman BT, Bacskai BJ. Curcumin labels amyloid pathology in vivo, disrupts existing plaques, and partially restores distorted neuritis in an Alzheimer mouse model. J Neurochem. 2007;102:1095-1104.
10. Thiyagarajan M, Sharma SS. Neuroprotective effect of curcumin in middle cerebral artery occlusion induced focal cerebral ischemia in rats. Life Sci. 2004;74:969-985.
11. Zhao J, Zhao Y, Zheng W, Lu Y, Feng G, Yu S. Neuroprotective effect of curcumin on transient focal cerebral ischemia in rats. Brain Res. 2008;1229:224-232.
12. Matteucci A, Frank C, Domenici MR, et al. Curcumin treatmentprotects rat retinal neurons against excitotoxicity: effect on Nmethyl- D-aspartate-induced intracellular Ca(2_) increase. Exp Brain Res. 2005;167:641-648.
13. Wang R, Li YB, Li YH, Xu Y, Wu HL, Li XJ. Curcumin protects against glutamate excitotoxicity in rat cerebral cortical neurons by increasing brain-derived neurotrophic factor level and activating TrkB. Brain Res. 2008;1210:84-91.
14. Osborne NN, Casson RJ, Wood JP, Chidlow G, Graham M, Melena J: Retinal ischemia: mechanisms of damage and potential therapeutic strategies. Prog Retin Eye Res. 2004;23:91-147.
15. Ng YK, Zeng XX, Ling EA. Expression of glutamate receptors and calcium-binding proteins in the retina of streptozotocin-induced diabetic rats. Brain Res. 2004;1018:66-72.
16. Wax MB, Tezel G. Neurobiology of glaucomatous optic neuropathy: diverse cellular events in neurodegeneration and neuroprotection. Mol Neurobiol. 2002;26:45-55.
17. Seki M, Lipton SA. Targeting excitotoxic/free radical signaling pathways for therapeutic intervention in glaucoma. Prog Brain Res. 2008;173:495-510.
18. Malchiodi-Albedi F, Domenici MR, Paradisi S, Bernardo A, Ajmone-Cat MA, Minghetti L. Astrocytes contribute to neuronal impairment in beta A toxicity increasing apoptosis in rat hippocampal neurons. Glia. 2001;34:68-72.
19. Malchiodi-Albedi F, Perilli R, Formisano G, Scorcia G, Caiazza S. Perfluorodecalin modifies the pattern of cell arrangement and induces loss of neurites in rat retinal cultures. J Biomed Mater Res. 1998;41:608-613.
20. Choi DW. Excitotoxic cell death. J Neurobiol. 1992;23:1261-1276.
21. Hamill OP, Marty A, Neher E, Sakmann B, Sigworth FJ. Improved patch-clamp techniques for high-resolution current recording from cells and cell-free membrane patches. Pflugers Arch. 1981; 391:85-100.
22. Liu Y, Wong TP, Aarts M, et al. NMDA receptor subunits have differential roles in mediating excitotoxic neuronal death both in vitro and in vivo. J Neurosci. 2007;27:2846-2857.
23. Yazawa K, Kihara T, Shen H, Shimmyo Y, Niidome T, Sugimoto H. Distinct mechanisms underlie distinct polyphenol-induced neuroprotection. FEBS Lett. 2006;580:6623-6628.
24. Brandstätter JH, Hartveit E, Sassoè-Pognetto M, Wässle H. Expression of NMDA and high-affinity kainate receptor subunit mRNAs in the adult rat retina. Eur J Neurosci. 1994;6:1100-1112.
25. Watanabe M, Mishina M, Inoue Y. Differential distributions of the NMDA receptor channel subunit mRNAs in the mouse retina. Brain Res. 1994;634:328-332.
26. Gründer T, Kohler K, Kaletta A, Guenther E. The distribution and developmental regulation of NMDA receptor subunit proteins in the outer and inner retina of the rat. J Neurobiol. 2000;44:333-342.
27. Fletcher EL, Hack I, Brandstätter JH, Wässle H. Synaptic localization of NMDA receptor subunits in the rat retina. J Comp Neurol. 2000;420:98-112.
28. Goebel DJ, Aurelia JL, Tai Q, Jojich L, Poosch MS. Immunocytochemical localization of the NMDA-R2A receptor subunit in the cat retina. Brain Res. 1998;808:141-154.
29. Zhou M, Baudry M. Developmental changes in NMDA neurotoxicity reflect developmental changes in subunit composition of NMDA receptors. J Neurosci. 2006;26:2956-2963.
30. Erreger K, Dravid SM, Banke TG, Wyllie DJ, Traynelis SF. Subunitspecific gating controls rat NR1/NR2A and NR1/NR2B NMDA channel kinetics and synaptic signaling profiles. J Physiol. 2005; 563:345-358.
31. Sobczyk A, Scheuss V, Svoboda K. NMDA receptor subunit-dependent [Ca2+] signaling in individual hippocampal dendritic spines. J Neurosci. 2005;25:6037-6046.